Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062114
Status:
COMPLETED
Last Update Posted:
2016-07-06
First Post:
2003-06-05
Brief Title:
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkins Lymphoma
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Organization Data
Organization:
Alliance for Clinical Trials in Oncology
Class:
OTHER
Study ID:
CALGB-50201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |